YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Phase 1
Not yet recruiting
- Conditions
- Alcohol Use Disorder (AUD)Alcohol UseAlcohol-Related Disorders
- Interventions
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 63
- Registration Number
- NCT06070649
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
Intradermal Influenza Vaccination
Early Phase 1
Recruiting
- Conditions
- Vaccine Reaction
- Interventions
- Device: MicronJetOther: Bacteriostatic SalineBiological: Fluzone® Quadrivalent
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Yale University
- Target Recruit Count
- 249
- Registration Number
- NCT06067555
- Locations
- 🇺🇸
Church Street Research Unit, New Haven, Connecticut, United States
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
Phase 1
Recruiting
- Conditions
- SchizophreniaCannabis Use Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Yale University
- Target Recruit Count
- 215
- Registration Number
- NCT06058702
- Locations
- 🇺🇸
West Haven Veterans Affairs Medical Center, West Haven, Connecticut, United States
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
Not Applicable
Recruiting
- Conditions
- Insulin Sensitivity
- Interventions
- Device: UltrasoundDiagnostic Test: CGM glucose readingDiagnostic Test: OGTT with unlabeled glucose and liver NMRDiagnostic Test: OGTT with carbon-13 labeled glucose and liver NMRDiagnostic Test: HEC - Hyperinsulinemic-Euglycemic-Clamp
- First Posted Date
- 2023-09-18
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 77
- Registration Number
- NCT06042517
- Locations
- 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States
Oral Dronabinol-HIV
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Yale University
- Target Recruit Count
- 160
- Registration Number
- NCT06034314
- Locations
- 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States
A Study of Sacituzumab Govitecan (IMMU-132) in Platinum-resistant Ovarian Cancer Patients
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2024-10-07
- Lead Sponsor
- Yale University
- Target Recruit Count
- 20
- Registration Number
- NCT06028932
- Locations
- 🇺🇸
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Recruiting
- Conditions
- Cesarean DeliveryGeneral Anesthesia
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Yale University
- Target Recruit Count
- 5000
- Registration Number
- NCT06030063
- Locations
- 🇺🇸
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
🇺🇸University of Arkansas, Little Rock, Arkansas, United States
🇺🇸University of California San Francisco, San Francisco, California, United States
Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use
Phase 1
Recruiting
- Conditions
- Cigarette SmokingSmoking CessationE-Cigarette Use
- Interventions
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Yale University
- Target Recruit Count
- 40
- Registration Number
- NCT06027840
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
Social Support Intervention for Addiction Recovery
Not Applicable
Completed
- Conditions
- Alcohol; Harmful UseAlcohol
- Interventions
- Behavioral: LDART
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Yale University
- Target Recruit Count
- 30
- Registration Number
- NCT06022107
- Locations
- 🇺🇸
1 Church St, New Haven, Connecticut, United States
PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
Phase 1
Withdrawn
- Conditions
- Muscarinic Receptor Occupancy
- Interventions
- Radiation: [11C]EMO ([11C]LSN3172176)
- First Posted Date
- 2023-08-28
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT06014385
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath